These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 17270076

  • 1. Applications of solid-state NMR to pharmaceutical polymorphism and related matters.
    Harris RK.
    J Pharm Pharmacol; 2007 Feb; 59(2):225-39. PubMed ID: 17270076
    [Abstract] [Full Text] [Related]

  • 2. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
    Liu J, Nagapudi K, Kiang YH, Martinez E, Jona J.
    Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
    Heinz A, Strachan CJ, Gordon KC, Rades T.
    J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Application of solid-state 35Cl NMR to the structural characterization of hydrochloride pharmaceuticals and their polymorphs.
    Hamaed H, Pawlowski JM, Cooper BF, Fu R, Eichhorn SH, Schurko RW.
    J Am Chem Soc; 2008 Aug 20; 130(33):11056-65. PubMed ID: 18656917
    [Abstract] [Full Text] [Related]

  • 9. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
    Reutzel-Edens SM.
    Curr Opin Drug Discov Devel; 2006 Nov 20; 9(6):806-15. PubMed ID: 17117688
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Solid-state NMR spectroscopy and its pharmaceutical use].
    Marosi A, Szalay Z, Demeter A.
    Acta Pharm Hung; 2010 Nov 20; 80(1):18-45. PubMed ID: 20443364
    [Abstract] [Full Text] [Related]

  • 13. Applications of process analytical technology to crystallization processes.
    Yu LX, Lionberger RA, Raw AS, D'Costa R, Wu H, Hussain AS.
    Adv Drug Deliv Rev; 2004 Feb 23; 56(3):349-69. PubMed ID: 14962586
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. One-phase crystal disorder in pharmaceutical solids and its implication for solid-state stability.
    Clawson JS, Kennedy-Gabb S, Lee AY, Copley RC.
    J Pharm Sci; 2011 Oct 23; 100(10):4302-16. PubMed ID: 21590691
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Terahertz pulsed spectroscopy and imaging in the pharmaceutical setting--a review.
    Zeitler JA, Taday PF, Newnham DA, Pepper M, Gordon KC, Rades T.
    J Pharm Pharmacol; 2007 Feb 23; 59(2):209-23. PubMed ID: 17270075
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.